| 000 -LEADER |
|---|
| fixed length control field |
04351nam a22003377a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240517142050.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240420b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323554732 [paperback] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
University of Cebu-Banilad |
| Transcribing agency |
University of Cebu-Banilad |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Willihnganz, Michelle J., |
| Relator term |
author. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Study guide for Clayton's basic pharmacology for nurses / |
| Statement of responsibility, etc |
Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce D. Clayton. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Eighteenth edition. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
St. Louis, Missouri : |
| Name of publisher, distributor, etc |
Elsevier, |
| Date of publication, distribution, etc |
c2020. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
v, 170 pages : |
| Other physical details |
illustrations (black and white) |
| Dimensions |
28 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type |
volume |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 1 Drug definitions, standards, and information sources -- Chapter 2 Basic principles of drug action and drug interactions -- Chapter 3 Drug action across the life span -- Chapter 4 The nursing process and pharmacology -- Chapter 5 Patient education to promote health -- Chapter 6 Principles of medication administration and medication safety -- Chapter 7 Percutaneous administration -- Chapter 8 Enteral administration -- Chapter 9 Parenteral administration: safe preparation of parenteral medications -- Chapter 10 Parenteral administration intradermal, subcutaneous, and intramuscular routes -- Chapter 11 Parenteral administration: intravenous route -- Chapter 12 Drugs that affect the autonomic nervous system -- Chapter 13 Drugs used for sleep -- Chapter 14 Drugs used to treat neurodegenerative disorders -- Chapter 15 Drugs used for anxiety disorders -- Chapter 16 Drugs used for depressive and bipolar disorders -- Chapter 17 Drugs used for psychoses -- Chapter 18 Drugs used for seizure disorders -- Chapter 19 Drugs used for pain management -- Chapter 20 Introduction to cardiovascular disease and metabolic syndrome -- Chapter 21 Drugs used to treat dyslipidemias -- Chapter 22 Drugs used to treat hypertension -- Chapter 23 Drugs used to treat dysrhythmias -- Chapter 24 Drugs used to treat angina pectoris -- Chapter 25 Drugs used to treat peripheral vascular disease -- Chapter 26 Drugs used to treat thromboembolic disorders -- Chapter 27 Drugs used to treat heart failure -- Chapter 28 Drugs used for diuresis -- Chapter 29 Drugs used to treat upper respiratory disease -- Chapter 30 Drugs used to treat lower respiratory disease -- Chapter 31 Drugs used to treat oral disorders -- Chapter 32 Drugs used to treat gastroesophageal reflux and peptic ulcer diseases -- Chapter 33 Drugs used to treat nausea and vomiting -- Chapter 34 Drugs used to treat constipation and diarrhea -- Chapter 35 Drugs used to treat diabetes mellitus -- Chapter 36 Drugs used to treat thyroid disease -- Chapter 37 Corticosteroid -- Chapter 38 Gonadal hormones -- Chapter 39 Drugs used in obstetrics -- Chapter 40 Drugs used in men's and women's health -- Chapter 41 Drug used to treat disorders of the urinary system -- Chapter 42 Drugs used to treat glaucoma and other eye disorders -- Chapter 43 Drugs used to treat cancer -- Chapter 44 Drugs used to treat the musculoskeletal system -- Chapter 45 Antimicrobial agents -- Chapter 46 Nutrition -- Chapter 47 Herbal and dietary supplement therapy -- Chapter 48 Substance abuse. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Reinforce your understanding of nursing pharmacology! Corresponding to the chapters from the main text, the Study Guide for Clayton’s Basic Pharmacology for Nurses, 18th Edition provides you with additional practice to help prepare for and succeed on the NCLEX®. Each exercise is linked to a chapter objective and various patient scenarios encourages you to use your knowledge of clinical pharmacology - further developing your critical thinking skills. Plus, a wide range of question formats reflects the question types you’ll encounter on the latest NCLEX. -- Provided by Publisher |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Adult |
| 541 ## - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Source of acquisition |
CD Books |
| Deans/Chairperson |
Apuhin, Mercy Milagros |
| Department |
College of Nursing |
| Subject Category |
Nursing |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
Text in English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology |
| General subdivision |
Problems, exercises, etc |
| 655 ## - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Problems, exercises, etc |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gurevitz, Samuel L., |
| Relator term |
author. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Clayton, Bruce D., |
| Relator term |
author. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Type of record |
Book |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| Encoded by |
Janna [new] |
| Date encoded |
04/20/2024 |
